Regeneration of pancreatic islets and reversal of diabetes by islet transcription factor genes delivered in vivo

Details for Australian Patent Application No. 2009313875 (hide)

Owner Baylor Research Institute

Inventors Grayburn, Paul A.; Chen, Shuyuan; Ding, Jiahuan

Agent Pizzeys

Pub. Number AU-A-2009313875

PCT Pub. Number WO2010/057045

Priority 61/114,407 13.11.08 US

Filing date 13 November 2009

Wipo publication date 20 May 2010

International Classifications

C12N 5/071 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Vertebrate cells or tissues, e.g. human cells or tissues

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

C12N 15/88 (2006.01) Mutation or genetic engineering

C12N 15/89 (2006.01) Mutation or genetic engineering

Event Publications

9 June 2011 PCT application entered the National Phase

  PCT publication WO2010/057045 Priority application(s): WO2010/057045

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009313877-CD37 immunotherapeutic combination therapies and uses thereof

2009313873-Selective drug delivery in a lumen